Funding for this research was provided by:
National Institues for Health (NIH R01 CA202911)
Text and Data Mining valid from 2020-01-10
Received: 2 October 2019
Accepted: 22 December 2019
First Online: 10 January 2020
Compliance with ethical standards
: PB (the Principal Investigator in this study) is a named inventor on patents relating to magnetic resonance imaging (MRI) and RF pulse design. The patents have been licensed to GE Healthcare, Siemens AG, and Philips International and PB receives royalty payments relating to these patents. PB is a named inventor on patents relating to Slice-selective adiabatic magnetization T2-preparation (SAMPA) for efficient T2-weighted imaging at ultrahigh field strengths, methods for producing a semi-adiabatic spectral-spatial spectroscopic imaging sequence and devices thereof, and semi-adiabatic spectral-spatial spectroscopic imaging. These patents have been filed through MSIP; they remain unlicensed, there is no discussion to license them in the near future, and there are consequently no royalties revolving around them. The remaining authors declare no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
: All procedures performed in the studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.